LeonaBio (LONA) Non-Current Assets (2019 - 2026)

LeonaBio (LONA) has 8 years of Non-Current Assets data on file, last reported at $2.4 million in Q1 2026.

• Quarterly Non-Current Assets fell 34.75% year-over-year to $2.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $11.4 million (down 30.35% YoY) and the FY2025 annual result came in at $2.7 million, down 31.62% from the prior year.
• Non-Current Assets slipped to $2.4 million in Q1 2026 per LONA's latest filing, from $2.7 million in the prior quarter.
• Across five years, Non-Current Assets topped out at $50.6 million in Q4 2022 and bottomed at $2.4 million in Q1 2026.
• The 5-year median for Non-Current Assets is $4.8 million (2024), against an average of $16.2 million.
• Peak annual rise in Non-Current Assets reached 9.06% in 2023, while the deepest fall reached 89.1% in 2023.
• Tracing LONA's Non-Current Assets over 5 years: stood at $50.6 million in 2022, then slumped by 89.1% to $5.5 million in 2023, then slipped by 28.61% to $3.9 million in 2024, then slumped by 31.62% to $2.7 million in 2025, then retreated by 11.33% to $2.4 million in 2026.
• Per Business Quant, the three latest LONA Non-Current Assets figures stand at $2.4 million (Q1 2026), $2.7 million (Q4 2025), and $3.0 million (Q3 2025).

Peer Comparison